60 related articles for article (PubMed ID: 27769360)
1. Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma.
Barman S; Bardhan I; Padhan J; Sudhamalla B
J Mol Graph Model; 2024 Jan; 126():108642. PubMed ID: 37797430
[TBL] [Abstract][Full Text] [Related]
2. Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8.
Wu T; Chen Y; You Q; Jiang Z; Chen X
Eur J Med Chem; 2024 Mar; 268():116271. PubMed ID: 38401187
[TBL] [Abstract][Full Text] [Related]
3. The polar warhead of a TRIM24 bromodomain inhibitor rearranges a water-mediated interaction network.
Liu J; Li F; Bao H; Jiang Y; Zhang S; Ma R; Gao J; Wu J; Ruan K
FEBS J; 2017 Apr; 284(7):1082-1095. PubMed ID: 28207202
[TBL] [Abstract][Full Text] [Related]
4. Bivalent Ligands for Protein Degradation in Drug Discovery.
Scheepstra M; Hekking KFW; van Hijfte L; Folmer RHA
Comput Struct Biotechnol J; 2019; 17():160-176. PubMed ID: 30788082
[TBL] [Abstract][Full Text] [Related]
5. The BRPF1 bromodomain is a molecular reader of di-acetyllysine.
Obi JO; Lubula MY; Cornilescu G; Henrickson A; McGuire K; Evans CM; Phillips M; Boyson SP; Demeler B; Markley JL; Glass KC
Curr Res Struct Biol; 2020; 2():104-115. PubMed ID: 33554132
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1.
Ghazy E; Zeyen P; Herp D; Hügle M; Schmidtkunz K; Erdmann F; Robaa D; Schmidt M; Morales ER; Romier C; Günther S; Jung M; Sippl W
Eur J Med Chem; 2020 Aug; 200():112338. PubMed ID: 32497960
[TBL] [Abstract][Full Text] [Related]
7. Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design.
Palomba T; Tassone G; Vacca C; Bartalucci M; Valeri A; Pozzi C; Cross S; Siragusa L; Desantis J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430693
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Proteomics of Induced Leukemia Cell Differentiation.
Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Archakov A; Zgoda V
Cells; 2022 Oct; 11(20):. PubMed ID: 36291090
[TBL] [Abstract][Full Text] [Related]
9. Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains.
Sekirnik AR; Reynolds JK; See L; Bluck JP; Scorah AR; Tallant C; Lee B; Leszczynska KB; Grimley RL; Storer RI; Malattia M; Crespillo S; Caria S; Duclos S; Hammond EM; Knapp S; Morris GM; Duarte F; Biggin PC; Conway SJ
ACS Chem Biol; 2022 Oct; 17(10):2753-2768. PubMed ID: 36098557
[TBL] [Abstract][Full Text] [Related]
10. Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment.
Mio C; Bulotta S; Russo D; Damante G
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30634442
[TBL] [Abstract][Full Text] [Related]
11. Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple).
Batiste L; Unzue A; Dolbois A; Hassler F; Wang X; Deerain N; Zhu J; Spiliotopoulos D; Nevado C; Caflisch A
ACS Cent Sci; 2018 Feb; 4(2):180-188. PubMed ID: 29532017
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.
Bennett J; Fedorov O; Tallant C; Monteiro O; Meier J; Gamble V; Savitsky P; Nunez-Alonso GA; Haendler B; Rogers C; Brennan PE; Müller S; Knapp S
J Med Chem; 2016 Feb; 59(4):1642-7. PubMed ID: 25974391
[TBL] [Abstract][Full Text] [Related]
13. Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.
Xiang Q; Luo G; Zhang C; Hu Q; Wang C; Wu T; Xu H; Hu J; Zhuang X; Zhang M; Wu S; Xu J; Zhang Y; Liu J; Xu Y
Eur J Med Chem; 2022 Jun; 236():114311. PubMed ID: 35385803
[TBL] [Abstract][Full Text] [Related]
14. Advancements in the Development of non-BET Bromodomain Chemical Probes.
Clegg MA; Tomkinson NCO; Prinjha RK; Humphreys PG
ChemMedChem; 2019 Feb; 14(4):362-385. PubMed ID: 30624862
[TBL] [Abstract][Full Text] [Related]
15. BET Bromodomain as a Target of Epigenetic Therapy.
Noguchi-Yachide T
Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
[TBL] [Abstract][Full Text] [Related]
16. Development of small molecule inhibitors of BRPF1 and TRIM24 bromodomains.
Palmer WS
Drug Discov Today Technol; 2016 Mar; 19():65-71. PubMed ID: 27769360
[TBL] [Abstract][Full Text] [Related]
17. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
